News
The drug development process necessitates the comprehensive evaluation of a candidate’s therapeutic benefits alongside its potential risks. Benefit–risk assessments are central to this ...
Please use one of the following formats to cite this article in your essay, paper or report: APA. DSI, a PLG Company. (2024, July 11). Nitrosamine assessment in drug production.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results